Jaleh Varshosaz Selected Research

Imatinib Mesylate (Gleevec)

3/2021	Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells.
1/2020	Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity.
1/2019	Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaleh Varshosaz Research Topics

Disease

34	Neoplasms (Cancer) 02/2024 - 05/2012
19	Breast Neoplasms (Breast Cancer) 05/2024 - 08/2016
19	Wounds and Injuries (Trauma) 03/2024 - 01/2011
9	Inflammation (Inflammations) 02/2024 - 10/2010
9	Ulcerative Colitis 01/2015 - 01/2009
8	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 09/2012
8	Colitis 01/2015 - 01/2010
7	Melanoma (Melanoma, Malignant) 05/2023 - 01/2014
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 08/2012
5	Infections 12/2023 - 12/2010
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2014
3	Cutaneous Leishmaniasis 01/2023 - 01/2021
3	Colonic Neoplasms (Colon Cancer) 09/2022 - 08/2012
3	Weight Gain 01/2012 - 01/2009
2	Pruritus (Itching) 01/2024 - 01/2021
2	Hemolysis 12/2023 - 01/2019
2	Weight Loss (Weight Reduction) 11/2023 - 01/2011
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2023 - 08/2022
2	Multiple Sclerosis 05/2023 - 08/2022
2	Edema (Dropsy) 02/2023 - 01/2011
2	Leishmaniasis 01/2023 - 01/2023
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 12/2019
2	Ulcer 06/2021 - 01/2010
2	Hypersensitivity (Allergy) 12/2020 - 12/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 08/2014
2	Lung Neoplasms (Lung Cancer) 08/2020 - 11/2015

Drug/Important Bio-Agent (IBA)

20	MicellesIBA 05/2023 - 05/2012
14	Docetaxel (Taxotere)FDA Link 11/2019 - 01/2015
9	ChitosanIBA 05/2024 - 12/2016
8	LipidsIBA 03/2021 - 08/2012
8	Dextrans (Dextran)FDA Link 01/2014 - 01/2009
8	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 01/2009
7	PolymersIBA 02/2024 - 04/2002
6	Acetic Acid (Vinegar)FDA LinkGeneric 01/2015 - 01/2010
5	polyacrylamideIBA 02/2024 - 01/2020
5	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 08/2012
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 01/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 08/2016
4	SolutionsIBA 02/2024 - 10/2010
4	HydrogelsIBA 05/2023 - 05/2012
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 04/2022
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2022 - 08/2017
4	maleic acid (maleate)IBA 11/2019 - 08/2016
4	AmidesIBA 11/2019 - 01/2018
4	ImidesIBA 11/2019 - 01/2018
4	Ether (Diethyl Ether)IBA 11/2019 - 01/2018
4	EstersIBA 11/2019 - 01/2018
4	Cytotoxins (Cytolysins)IBA 06/2018 - 08/2012
4	SuspensionsIBA 02/2011 - 01/2010
3	CollagenIBA 03/2024 - 03/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2024 - 09/2022
3	Keratins (Keratin)IBA 02/2024 - 04/2023
3	PectinsIBA 12/2023 - 01/2012
3	GelatinIBA 04/2023 - 01/2017
3	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 10/2019
3	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 01/2021
3	Saline SolutionIBA 08/2022 - 01/2015
3	Silicon Dioxide (Silica)FDA LinkGeneric 08/2022 - 01/2011
3	Imatinib Mesylate (Gleevec)FDA Link 03/2021 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 08/2020 - 01/2019
3	Raloxifene Hydrochloride (Evista)FDA Link 11/2019 - 01/2018
3	Styrene (Styrol)IBA 11/2019 - 01/2018
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 08/2016
3	CholesterolIBA 01/2016 - 08/2012
2	poly-N-isopropylacrylamideIBA 05/2024 - 10/2021
2	Arginine (L-Arginine)FDA Link 02/2024 - 09/2022
2	Liposomes (Liposome)IBA 12/2023 - 01/2014
2	ribociclibIBA 12/2023 - 08/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 04/2023
2	Phosphates (Orthophosphate)IBA 11/2023 - 04/2023
2	GoldIBA 11/2023 - 12/2019
2	polydopamineIBA 05/2023 - 08/2022
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2023 - 01/2019
2	CarrageenanIBA 04/2023 - 02/2023
2	CytokinesIBA 02/2023 - 01/2022
2	Hyaluronic Acid (Hyaluronan)IBA 01/2023 - 01/2014
2	FlavonoidsIBA 01/2023 - 09/2022
2	polycaprolactoneIBA 01/2023 - 06/2010
2	Small Interfering RNA (siRNA)IBA 12/2022 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2022
2	Glutathione (Reduced Glutathione)IBA 08/2022 - 03/2022
2	AcidsIBA 08/2022 - 01/2022
2	gellan gumIBA 08/2022 - 03/2022
2	Glucosamine (Dona)IBA 08/2022 - 08/2020
2	TabletsIBA 04/2022 - 02/2011
2	Sunitinib (Sutent)FDA Link 01/2022 - 12/2019
2	methylallyl trisulfide (MATS)IBA 10/2021 - 01/2011
2	BoronIBA 10/2021 - 10/2021
2	Alanine (L-Alanine)FDA Link 10/2021 - 10/2021
2	Doxycycline (Periostat)FDA LinkGeneric 06/2021 - 03/2020
2	Matrix Metalloproteinase InhibitorsIBA 06/2021 - 03/2020
2	Rituximab (Mabthera)FDA Link 03/2021 - 01/2020
2	SolventsIBA 01/2021 - 01/2015
2	Retinaldehyde (Retinal)IBA 12/2020 - 12/2019
2	Antineoplastic Agents (Antineoplastics)IBA 08/2020 - 01/2018
2	Dosage Forms (Dosage Form)IBA 08/2020 - 07/2016
2	punicic acidIBA 07/2020 - 01/2020

Therapy/Procedure

10	Therapeutics 05/2024 - 01/2014
4	Drug Therapy (Chemotherapy) 05/2022 - 01/2014
3	Radiotherapy 11/2023 - 11/2022